Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promise as Neuroprotective Agents in Neonates.

about

Neuroprotective potential of erythropoietin in neonates; design of a randomized trial.Packed red blood cell transfusions as a risk factor for parenteral nutrition associated liver disease in premature infants.

P2860

Q31071784-A4D3CCB8-1371-4E95-817A-5D80801A080F Q39016190-DF28B119-B8DB-4657-9809-EEFB2577FA1E

P2860

Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promise as Neuroprotective Agents in Neonates.

Item

http://www.wikidata.org/entity/Q42949621

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Erythropoiesis Stimulating Age ...... protective Agents in Neonates.

@en

Erythropoiesis Stimulating Age ...... protective Agents in Neonates.

@nl

type

Item

label

Erythropoiesis Stimulating Age ...... protective Agents in Neonates.

@en

Erythropoiesis Stimulating Age ...... protective Agents in Neonates.

@nl

prefLabel

Erythropoiesis Stimulating Age ...... protective Agents in Neonates.

@en

Erythropoiesis Stimulating Age ...... protective Agents in Neonates.

@nl

P1476

Erythropoiesis Stimulating Age ...... protective Agents in Neonates.

@en

P2093

John A Widness

http://www.w3.org/2001/XMLSchema#string

Robert D Christensen

http://www.w3.org/2001/XMLSchema#string

Robin K Ohls

http://www.w3.org/2001/XMLSchema#string

Sandra E Juul

http://www.w3.org/2001/XMLSchema#string

P2860

Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants

Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants

Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants

Outcomes of extremely low birth weight infants given early high-dose erythropoietin.

Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age.

Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy.

Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo.

Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.

A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants

P304

10-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1016/J.JPEDS.2015.03.054

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275586582

http://www.w3.org/2001/XMLSchema#string

P698

25917767

http://www.w3.org/2001/XMLSchema#string

P932

4795451

http://www.w3.org/2001/XMLSchema#string

Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promise as Neuroprotective Agents in Neonates.

about

P2860

P2860

Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promise as Neuroprotective Agents in Neonates.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932